Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | FSHR | P23945 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CD44 | P16070 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21775183 | 0.87 | CYP19A1 (0.39) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL807632 | 0.81 | MEN1 (0.44) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL2686247 | 0.76 | CYP19A1 (0.41) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL8067833 | 0.75 | FSHR (0.38) | MEN1MAPTKMT2ASMN1; SMN2FSHR | |
| SCHEMBL27862690 | 0.74 | FSHR (0.44) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL140434 | 0.72 | FSHR (0.42) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL29409547 | 0.72 | FSHR (0.42) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL137367 | 0.72 | FSHR (0.42) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL29374824 | 0.72 | FSHR (0.42) | CYP19A1LMNAKDM4EMEN1MAPT | |
| SCHEMBL9843871 | 0.72 | CYP19A1 (0.36) | CYP19A1FSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200075862-A1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2020-03-05 | — | — | US | claimed |
| CN-110740986-A | Indane derivatives and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2020-01-31 | — | — | CN | claimed |
| JP-11172181-A | — | — | None | — | — | JP | disclosed |
| EP-3621946-B1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2023-09-06 | — | — | EP | disclosed |
| US-11495746-B2 | Indane derivatives and their use in organic electronics | DOTTIKON ES HOLDING AG (CH) | 2022-11-08 | — | — | US | disclosed |
| US-20200075862-A1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2020-03-05 | — | — | US | disclosed |
| CN-110740986-A | Indane derivatives and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2020-01-31 | — | — | CN | disclosed |
| JP-H11172181-A | PRINTING INK COMPOSITION | TOSHIBA CHEM CORP | 1999-06-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11495746-B2 | Indane derivatives and their use in organic electronics | KCNJ2, KCNA2, CYP2J2 | CYP19A1 168/4885LMNA 1182/4885KDM4E 3294/4885 |
| US-20200075862-A1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | KCNJ2, KCNA2, CYP2J2 | CYP19A1 168/4885LMNA 1182/4885KDM4E 3294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.